Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by the reflux of gastric contents into the esophagus, leading to symptoms like heartburn and complications such as esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Endoscopy, specifically upper gastrointestinal endoscopy, is critical in diagnosing and managing GERD, especially in patients with alarm symptoms, refractory cases, or suspected complications. It allows for direct visualization, biopsy, and therapeutic interventions, including endoscopic fundoplication, radiofrequency ablation, and mucosal resection. Recent advancements, such as narrow band imaging, confocal laser endomicroscopy, and AI-driven diagnostics, have enhanced the detection of early disease and improved patient outcomes. As endoscopic techniques evolve, they offer minimally invasive, personalized treatment options, shaping the future of GERD management.
Gastroesophageal reflux disease (GERD) is a common chronic condition that affects millions of people globally. It is characterized by the reflux of stomach contents, particularly acidic gastric juice, into the esophagus, leading to symptoms such as heartburn, regurgitation, and dysphagia. Over time, GERD can result in complications such as esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Endoscopy, particularly upper gastrointestinal endoscopy (esophagogastroduodenoscopy or EGD), plays a pivotal role in diagnosing and managing GERD.1-5
Endoscopy provides a direct view of the esophagus, stomach, and duodenum, allowing clinicians to assess the mucosal surface, detect complications of GERD, and perform therapeutic interventions when necessary. While the diagnosis of GERD is often clinical, especially in uncomplicated cases, endoscopy is crucial in confirming the diagnosis in patients with alarm symptoms, evaluating the severity of esophagitis, detecting complications, and guiding management strategies.6-8
This article provides a comprehensive overview of the role of endoscopy in diagnosing and managing GERD, discusses current trends in endoscopic techniques, and explores emerging technologies that are reshaping the field of GERD management.
GERD occurs when the lower esophageal sphincter (LES) fails to maintain an adequate barrier between the stomach and the esophagus. The LES is a ring of muscle located at the junction of the esophagus and stomach, and its relaxation or incompetence allows gastric contents to flow back into the esophagus. The severity of GERD is influenced by factors such as the frequency of reflux events, the volume of refluxed material, and the ability of the esophagus to clear the acidic contents.
Other contributing factors to GERD include impaired esophageal motility, delayed gastric emptying, and increased intra-abdominal pressure, which may occur due to obesity or pregnancy. Lifestyle factors such as smoking, alcohol consumption, and certain dietary habits (e.g., high-fat meals, chocolate, caffeine) can also exacerbate GERD symptoms.
The typical symptoms of GERD include heartburn (a burning sensation in the chest) and acid regurgitation (the backflow of stomach acid into the throat or mouth). Other symptoms may include chest pain, dysphagia (difficulty swallowing), chronic cough, and hoarseness. GERD can also manifest as extra-esophageal symptoms such as asthma, laryngitis, and dental erosions.
In most patients, GERD is diagnosed based on clinical symptoms and response to proton pump inhibitors (PPIs). However, endoscopy is indicated in patients with alarm features such as dysphagia, odynophagia (painful swallowing), weight loss, anemia, or those with suspected complications like Barrett’s esophagus or esophageal adenocarcinoma.
Endoscopy is not required in all patients with GERD, particularly in those with uncomplicated symptoms that respond well to acid-suppressive therapy. However, endoscopy is essential in the following scenarios:
The most common findings in GERD during endoscopy include:
In addition to visualizing the esophageal mucosa, endoscopy allows for tissue sampling (biopsy), which is essential for confirming the presence of complications like Barrett’s esophagus and ruling out malignancies or other causes of esophageal inflammation. Biopsy specimens can reveal histopathological features such as:
While most GERD patients are managed with lifestyle modifications and pharmacotherapy, a subset of patients with refractory symptoms or those seeking alternatives to long-term PPI use may benefit from endoscopic therapies. These procedures aim to enhance the function of the LES and reduce acid reflux. Common endoscopic treatments include:
Transoral incisionless fundoplication (TIF) is an endoscopic procedure that replicates the effects of surgical fundoplication without the need for incisions. During TIF, the esophagus is accessed through the mouth, and a specialized device is used to create a partial wrap of the gastric fundus around the lower esophagus, enhancing the pressure of the LES and preventing reflux.
Studies have shown that TIF can improve GERD symptoms, reduce PPI dependence, and improve quality of life. However, its long-term efficacy is still being evaluated, and it may not be suitable for patients with large hiatal hernias.
The Stretta procedure involves the delivery of radiofrequency energy to the muscles of the LES and gastric cardia. This energy induces controlled scarring, leading to the thickening of the LES and reduction of reflux episodes.
While some studies have reported improvements in GERD symptoms following the Stretta procedure, its use remains controversial, with some clinical guidelines recommending caution due to inconsistent long-term results.
Endoscopy is crucial not only for diagnosing GERD-related complications but also for managing them:
Esophageal strictures can cause progressive dysphagia and significantly impair quality of life. Endoscopic dilation, using either balloon or bougie dilators, is an effective and safe method for relieving esophageal strictures. In some cases, multiple sessions may be required to achieve optimal results.
For patients with Barrett’s esophagus and early esophageal adenocarcinoma, endoscopic mucosal resection (EMR) is a minimally invasive alternative to surgery. During EMR, the superficial layers of the esophagus, containing the abnormal or cancerous tissue, are removed endoscopically. This procedure allows for the removal of dysplastic or early neoplastic tissue without the need for more extensive surgery.
In patients with Barrett’s esophagus and low-grade or high-grade dysplasia, radiofrequency ablation (RFA) is used to destroy the dysplastic cells. During RFA, a catheter-mounted balloon is passed through the endoscope, and radiofrequency energy is delivered to the affected areas of the esophagus, ablating the abnormal tissue.
RFA has been shown to be highly effective in eradicating dysplasia and reducing the risk of progression to esophageal adenocarcinoma. In combination with surveillance endoscopy, RFA is an important tool in the management of Barrett’s esophagus.
Endoscopic technologies have evolved significantly, improving the ability to detect subtle lesions and early-stage disease. Advanced imaging techniques include:
Narrow band imaging (NBI) enhances the visualization of the mucosal surface and vasculature by using specific wavelengths of light. This technique improves the detection of early mucosal changes in Barrett’s esophagus and other GERD-related conditions, facilitating early diagnosis and intervention.
Confocal laser endomicroscopy (CLE) is an advanced imaging technique that allows for real-time, in vivo microscopic evaluation of the esophageal mucosa. CLE can differentiate between normal and dysplastic tissue at a cellular level, enhancing the accuracy of biopsy targeting in Barrett’s esophagus.
Artificial intelligence (AI) is revolutionizing the field of endoscopy, with the development of AI-powered systems that can assist in the detection and diagnosis of GERD-related lesions. AI algorithms, trained on large datasets of endoscopic images, can detect abnormalities such as esophagitis, Barrett’s esophagus, and early-stage cancer with high accuracy.
AI has the potential to reduce interobserver variability, improve diagnostic accuracy, and enhance the efficiency of endoscopic procedures. As AI technology continues to advance, it is likely to play an increasingly important role in GERD management.
As the understanding of GERD continues to evolve, so too will the role of endoscopy in its diagnosis and management. Emerging technologies and therapeutic innovations are reshaping the landscape of GERD treatment, offering new opportunities to enhance patient care.
Several novel endoscopic devices are under investigation for the treatment of GERD. These devices aim to restore the function of the LES and prevent reflux without the need for surgery. Examples include the magnetic sphincter augmentation device (LINX), which uses a ring of magnetic beads to reinforce the LES, and endoscopic suturing devices that tighten the LES.
The future of GERD management may involve personalized approaches, in which endoscopic findings and patient characteristics are used to tailor treatment strategies. For example, patients with mild GERD and no complications may be managed conservatively with lifestyle modifications and PPIs, while those with refractory GERD or high-risk Barrett’s esophagus may benefit from endoscopic interventions.
Endoscopy plays an essential role in both the diagnosis and management of gastroesophageal reflux disease. It is indispensable for identifying complications such as esophagitis, Barrett’s esophagus, and esophageal cancer, and for guiding treatment strategies in patients with refractory symptoms or those at risk for progression. In addition, endoscopic therapies, such as TIF, radiofrequency ablation, and endoscopic resection, offer minimally invasive alternatives to surgery, improving outcomes for patients with GERD and its complications.
As technology continues to advance, the integration of AI, advanced imaging techniques, and novel therapeutic devices will further enhance the role of endoscopy in GERD management. With these innovations, endoscopy is set to remain at the forefront of GERD care, providing patients with more effective, personalized, and less invasive treatment options.